MCMCB Pro
M1332

M1332Patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 2 weeks

HCPCSActiveBETOS Z2

M1332 is a HCPCS Level II code for patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 2 weeks. It belongs to the Medical Services section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusM

Measurement code. Used for reporting purposes only; never paid.

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

The CMS record for M1332

Long descriptor
Patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 2 weeks

The official wording. This is what the code means.

Short descriptor
Pts no eval ini xm no 2 wks

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2024

When CMS introduced the code.

BETOS
Z2

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
00 — Not priced by Part B

Service not separately priced by Part B — not covered, bundled into another service, or used by Part A only.

Codes adjacent to M1332

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If M1332 is not quite right, the correct code is very often within a few positions of it.

  • M1324Patients who had an intravitreal or periocular corticosteroid injection (e.g., triamcinolone, preservative-free triamcinolone, dexamethasone, dexamethasone intravitreal implant, or fluocinolone intravitreal implant)
  • M1325Patients who were not seen for reasons documented by clinician for patient or medical reasons (e.g., inadequate time for follow-up, patients who received a prior intravitreal or periocular steroid injection within the last six (6) months and had a subsequent iop evaluation with iop <25mm hg within seven (7) weeks of treatment)
  • M1326Patients with a diagnosis of hypotony
  • M1327Patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 8 weeks
  • M1328Patients with a diagnosis of acute vitreous hemorrhage
  • M1329Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 8 weeks after initial acute pvd encounter
  • M1330Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up)
  • M1331Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 8 weeks from initial exam
  • M1333Acute vitreous hemorrhage
  • M1334Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 2 weeks after initial acute pvd encounter
  • M1335Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up)
  • M1336Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 2 weeks
  • M1337Acute pvd
  • M1338Patients who had follow-up assessment 30 to 180 days after the index assessment who did not demonstrate positive improvement or maintenance of functioning scores during the performance period
  • M1339Patients who had follow-up assessment 30 to 180 days after the index assessment who demonstrated positive improvement or maintenance of functioning scores during the performance period
  • M1340Index assessment completed using the 12-item whodas 2.0 or sds during the denominator identification period

Questions about M1332

What is HCPCS code M1332?

M1332 is a HCPCS Level II code for patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 2 weeks. It sits in the Medical Services section.

Does Medicare cover M1332?

The CMS HCPCS file marks M1332 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

How is M1332 paid under the physician fee schedule?

M1332 carries PFS status code M. Measurement code. Used for reporting purposes only; never paid.

HCPCS Level II2026Q3-Jul· effective July 1, 2026